IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biolinerx LTD (BLRX)

CUSIP: 09071M304 | US | Healthcare · Biotechnology | Micro Cap | 30 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Rhumbline Advisers2,478
0.0% of portfolio›$5.8K
Nemes Rush Group LLC250
0.0% of portfolio›$588
UBS Group AG157
0.0% of portfolio›$369
SBI Securities Co., Ltd.10
0.0% of portfolio›$24
Caitong International Asset Management Co., Ltd2
0.0% of portfolio›$5
Danske Bank A/S2
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Rhumbline Advisers
2,478$5.8K0.0%IndexVery LowBoston, MA2026-11-10
Nemes Rush Group LLC
250$5880.0%GrowthLowNovi, MI2026-11-04
UBS Group AG
157$3690.0%CoreMediumZurich, Switzerland2026-11-10
SBI Securities Co., Ltd.
10$240.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
2$50.0%GrowthVery HighHong Kong, South Korea2026-10-29
Danske Bank A/S
2$50.0%GrowthLowCopenhagen V, Greece2026-11-09